ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
4.100
+0.050 (1.23%)
Oct 30, 2026, 4:00 PM EDT - Market closed
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $46.54 million as of October 30, 2026. It is the 30,662nd most valuable company in the world and the 4,671st biggest in the United States. Its market cap has decreased by 52.65% in one year.
Market Cap
46.54M
Enterprise Value
-87.70M
1-Year Change
-52.65%
Global Rank
Country Rank
#4,671 United States
Category
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $46.54M, a decrease of -74.57%. That is a compound annual growth rate of -66.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 46.54M | -39.68% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 51.52M |
| Gain Therapeutics | 51.50M |
| iBio, Inc. | 50.99M |
| Caribou Biosciences | 50.71M |
| Elicio Therapeutics | 48.10M |
| LeonaBio | 47.11M |
| Mereo BioPharma Group | 46.42M |
| Kalaris Therapeutics | 45.94M |